Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer's disease diagnosis: a pilot study in England.

Dell'Agnello G, Desai U, Kirson NY, Wen J, Meiselbach MK, Reed CC, Belger M, Lenox-Smith A, Martinez C, Rasmussen J.

BMJ Open. 2018 Mar 22;8(3):e019684. doi: 10.1136/bmjopen-2017-019684.

2.

Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study.

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW.

BMC Geriatr. 2018 Feb 23;18(1):57. doi: 10.1186/s12877-018-0748-9.

4.

Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.

Happich M, Kirson NY, Desai U, King S, Birnbaum HG, Reed C, Belger M, Lenox-Smith A, Price D.

J Alzheimers Dis. 2016 May 6;53(1):171-83. doi: 10.3233/JAD-150685.

5.

Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?

Marchettini P, Wilhelm S, Petto H, Tesfaye S, Tölle T, Bouhassira D, Freynhagen R, Cruccu G, Lledó A, Choy E, Kosek E, Micó JA, Späth M, Skljarevski V, Lenox-Smith A, Perrot S.

Eur J Pain. 2016 Mar;20(3):472-82. doi: 10.1002/ejp.763. Epub 2015 Aug 27.

PMID:
26311228
6.

Treatment and outcomes for patients with depression who are partial responders to SSRI treatment: post-hoc analysis findings from the FINDER European observational study.

Lenox-Smith A, Martinez JM, Perahia D, Dowsett SA, Dennehy EB, Lopez-Romero P, Demyttenaere K.

J Affect Disord. 2014 Dec;169:149-56. doi: 10.1016/j.jad.2014.08.003. Epub 2014 Aug 12.

PMID:
25194783
7.

Individual residual symptoms and functional impairment in patients with depression.

Romera I, Pérez V, Quail D, Berggren L, Lenox-Smith A, Gilaberte I.

Psychiatry Res. 2014 Dec 15;220(1-2):258-62. doi: 10.1016/j.psychres.2014.07.042. Epub 2014 Aug 1.

PMID:
25149132
8.
9.

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.

Alaka KJ, Noble W, Montejo A, Dueñas H, Munshi A, Strawn JR, Lenox-Smith A, Ahl J, Bidzan L, Dorn B, Ball S.

Int J Geriatr Psychiatry. 2014 Sep;29(9):978-86. doi: 10.1002/gps.4088. Epub 2014 Feb 20.

10.

Impact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressants.

Mancini M, Wade AG, Perugi G, Lenox-Smith A, Schacht A.

J Psychiatr Res. 2014 Apr;51:21-9. doi: 10.1016/j.jpsychires.2014.01.001. Epub 2014 Jan 13.

11.

Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study.

Lenox-Smith A, Macdonald MT, Reed C, Tylee A, Peveler R, Quail D, Wildgust HJ.

Neurol Ther. 2013 Mar 13;2(1-2):25-42. doi: 10.1007/s40120-013-0006-1. eCollection 2013 Dec.

13.

A 12-week nursing support programme for carers of children and adolescents in the UK with attention deficit hyperactivity disorder prescribed atomoxetine.

Savill N, Pelton J, Lenox-Smith A, Bushe CJ.

Ther Adv Psychopharmacol. 2013 Apr;3(2):65-71. doi: 10.1177/2045125312465305.

14.
15.
16.
17.

Meta-analyses and antidepressant prescribing.

Lenox-Smith A, D'yachkova Y, Deberdt W, Raskin J.

J Psychopharmacol. 2010 Apr;24(4):629-30. doi: 10.1177/0269881110364440. No abstract available.

PMID:
20360160
18.

Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge.

Hood SD, Melichar JK, Taylor LG, Kalk N, Edwards TR, Hince DA, Lenox-Smith A, Lingford-Hughes AR, Nutt DJ.

J Psychopharmacol. 2011 Jan;25(1):78-86. doi: 10.1177/0269881109359099. Epub 2010 Jan 21.

PMID:
20093317
19.

Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.

Lenox-Smith A, Greenstreet L, Burslem K, Knight C.

Clin Drug Investig. 2009;29(3):173-84. doi: 10.2165/00044011-200929030-00004. Erratum in: Clin Drug Investig. 2010;30(1):70.

PMID:
19243210
20.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
21.
22.

Value in venlafaxine study.

Lenox-Smith A.

Br J Gen Pract. 2004 Apr;54(501):303-4. No abstract available.

23.

Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UK.

Lenox-Smith A, Conway P, Knight C.

Pharmacoeconomics. 2004;22(5):311-9.

PMID:
15061681
24.

Response to 'Wishful pharmaceutical thinking'.

Lenox-Smith A.

Br J Gen Pract. 2004 Jan;54(498):57. No abstract available.

26.

Bisoprolol alone and in combination with amlodipine or nifedipine in the treatment of chronic stable angina.

Ferguson JD, Ormerod O, Lenox-Smith AJ.

Int J Clin Pract. 2000 Jul-Aug;54(6):360-3.

PMID:
11092108
27.

Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United Kingdom.

Freeman H, Arikian S, Lenox-Smith A.

Pharmacoeconomics. 2000 Aug;18(2):143-8.

PMID:
11067648
28.

Psychotropic drug treatment. Some antidepressants are more effective than others.

Lenox-Smith A.

BMJ. 1998 Feb 7;316(7129):476; discusson 477. No abstract available.

29.

Comparison of ramipril against atenolol in controlling mild-to-moderate hypertension.

Lenox-Smith AJ, Street RB, Kendall FD.

J Cardiovasc Pharmacol. 1991;18 Suppl 2:S150-2.

PMID:
1725029
30.

Oligosymptomatic hypocalcaemia in a patient with impaired parathyroid hormone activity.

Lenox-Smith A, Smith W, Ferns GA, Moniz C.

J R Soc Med. 1988 Dec;81(12):732-3. No abstract available.

Supplemental Content

Loading ...
Support Center